Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04049552 · ClinicalTrials.gov registry record · Early Phase 1
RAPA-Keloid Study of Keloid Regression
A Early Phase 1 study of Keloid, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT04049552 is a Early Phase 1 study of Keloid that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 4 participants, below the 2,144-participant average among 8 other Keloid trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04049552, a Early Phase 1 study of Keloid, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
1. To test whether topical rapamycin regresses established keloids in humans by measuring surface area and height changes in the scar over time (6 months) 2. To test safety of product and feasibility of conduct for future clinical trial
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Rapamycin 8% Ointment
Study Locations (1)
Texas
- Audie L Murphy Memorial Veterans Hospital - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2020-01-24 |
| Est. Completion | 2021-05-02 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04049552
The ClinicalTrials.gov registry entry for NCT04049552 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,144-participant average among 8 other Keloid trials with a reported enrollment target (100% lower). The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Keloid appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04049552 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04049552 about?
NCT04049552 is a clinical study titled "RAPA-Keloid Study of Keloid Regression". 1. To test whether topical rapamycin regresses established keloids in humans by measuring surface area and height changes in the scar over time (6 months) 2. To test safety of product and feasibility of conduct for future clinical trial
What is the current status of trial NCT04049552?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 4 participants. The study started on 2020-01-24. Estimated completion is 2021-05-02.
What conditions does trial NCT04049552 study?
This clinical trial studies the following conditions: Keloid.
What interventions are being tested in trial NCT04049552?
The interventions under investigation include: Placebo (DRUG), Rapamycin 8% Ointment (DRUG).
Who is sponsoring clinical trial NCT04049552?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04049552 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keloid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids
COMPLETED · Early Phase 1
-
Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy
RECRUITING · Phase 2
-
Radiotherapy for Keloids
RECRUITING · NA
-
Genetic Analysis of Keloids
RECRUITING
-
Web Based Investigation of Natural History of Keloid Disorder, an Online Survey
RECRUITING
-
Pilot Study Investigating a Restorative Wound Care Cream Together With Petrolatum on Surgical Excisions
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.